← Leaderboards
Matthew Banks
Wake Forest University Health Sciences
$4,322,168
Attributed
$7,032,031
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,032,031 · 8
By mechanism
R01$5,532,353 · 4
R21$767,076 · 2
R34$689,020 · 1
F31$43,582 · 1
Top collaborators
- Peter James Hamilton5 shared
- Katherine L Nicholson5 shared
- Jose Miguel Eltit3 shared
- Kaitlin Elizabeth Bountress2 shared
- Gretchen N Neigh2 shared
Most similar at Wake Forest University Health Sciences
Same institution · by research overlap
- Jeffrey L. Weiner$14,355,522
- Yuval Silberman$3,804,463
- Samuel Centanni$3,764,211
- James Melchior$272,047
- Sara R Jones$17,205,673
Others in their field
Top investigators on “Pre-Clinical”
- Leonard Freedman · Leidos Biomedical Research, Inc.$264,541,531
- Dennis R. Burton · Scripps Research Institute$257,157,696
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$212,820,795
- Barton F Haynes · Duke University$186,001,832
- David Heimbrook · Leidos Biomedical Research, Inc.$151,740,590
- Reisa A. Sperling · Banner Health$137,047,788
Research focus
Pre-ClinicalDrug AddictionPharmaceutical PreparationsBehavioralBehaviorSelf AdministrationProceduresFoodInnovationAgonistAttenuatedMethamphetamineAddictionNon-DrugOpioidReinforcerRattusResponseMacaca MulattaWithdrawalPharmacotherapyPerformanceMaleOpiate Addiction
Grant awards (22)
Cell type transcriptional mechanisms of polysubstance choice$461,523
R01 · FY2025 · DA
Pharmacology of Stimulant Choice$349,313
R01 · FY2025 · DA · contact PI
Neurocognitive, genetic and socioenvironmental influences on a developmental precursors to addiction: A cross-species study$342,109
R34 · FY2025 · DA
Cell type transcriptional mechanisms of polysubstance choice$471,892
R01 · FY2024 · DA
Pharmacology of Stimulant Choice$349,313
R01 · FY2024 · DA · contact PI
Neurocognitive, genetic and socioenvironmental influences on a developmental precursors to addiction: A cross-species study$346,911
R34 · FY2024 · DA
Cell type transcriptional mechanisms of polysubstance choice$443,135
R01 · FY2023 · DA
Pharmacology of Stimulant Choice$349,313
R01 · FY2023 · DA · contact PI
The role of negative reinforcement in drug abuse$194,063
R21 · FY2022 · DA · contact PI
The role of negative reinforcement in drug abuse$219,063
R21 · FY2021 · DA · contact PI
Behavioral effects of NMDA antagonist/opioid agonist combinations$374,616
R01 · FY2018 · DA
Behavioral effects of NMDA antagonist/opioid agonist combinations$373,282
R01 · FY2017 · DA
Behavioral effects of NMDA antagonist/opioid agonist combinations$389,892
R01 · FY2016 · DA
Behavioral effects of NMDA antagonist/opioid agonist combinations$383,638
R01 · FY2015 · DA
Behavioral effects of NMDA antagonist/opioid agonist combinations$440,280
R01 · FY2014 · DA
Treatment Development for Methamphetamine Abuse$396,740
R01 · FY2014 · DA · contact PI
Effect of reinforcer type in cognitive behaviors$185,375
R21 · FY2014 · DA · contact PI
Treatment Development for Methamphetamine Abuse$393,140
R01 · FY2013 · DA · contact PI
Effect of reinforcer type in cognitive behaviors$168,575
R21 · FY2013 · DA · contact PI
Treatment Development for Methamphetamine Abuse$356,276
R01 · FY2012 · DA · contact PI
Role of Thermoregulation in MDMA Abuse$20,060
F31 · FY2006 · DA · contact PI
Role of Thermoregulation in MDMA Abuse$23,522
F31 · FY2005 · DA